Clinicopathological features of perforated colorectal cancer

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1681-1684

  Ogawa, Masaichi ^a   Watanabe, Michiaki ^a   Eto, Ken ^a   Omachi, Takahiro ^a   Kosuge, Makoto ^a   Hanyu, Ken ^a   Noaki, Lohta ^a   Fujita, Tetsuji ^a   Yanaga, Katsuhtko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinico pathological features; Colorectal cancer; Hartmann's procedure; Perforation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLON SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE PERFORATION; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE;

COLORECTAL NEOPLASMS; HUMANS; RETROSPECTIVE STUDIES;

EID: 67650085111     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Badia JM, Sitges-Serra A, Pla J et al: Perforation of colonic neoplasms: a review of 36 cases. Int J Colorectal Dis 2(4): 187-189, 1987.
2. Mandava N, Kumar S, Pizzi S et al: Perforated colorectal carcinomas. Am J Surg 172(3): 236-238, 1996.
3. Lee IK, Sung NY, Lee SC et al: The survival rate and prognostic factors in 26 perforated colorectal patients. Int J Colorectal Dis 22(5): 467-473, 2007. (Pubitemid 46488050)
4. Corman ML: Principles of surgical technique in the treatment of carcinoma of large bowel. World J Surg 15: 592-1586, 1991.
5. Phillips RKS: Clinical factors which influence outcome after colorectal cancer surgery. Modern Coloproctol 4: 69-79, 1993.
6. Korenaga D, Ueno H, Mochida K et al: Prognosis factors in Japanese patients with colorectal cancer: the significant of the large bowel obstruction: univariate and multivariate analysis. J Surg Oncol 47(3): 188-192, 1991.
7. Gullino D, Giordano O, Masella M et al: The single-stage surgery of perforated colon carcinoma: our experience of 46 cases. Mineva Chir 54(3): 127-137, 1999. (Pubitemid 29213331)
8. Steinberg SM, Barkin JS, Kaplan RS et al: Prognostic indicators of colon tumors: the gastrointestinal tumor study group experience. Cancer 57: 1866-1870, 1986. (Pubitemid 16112004)
9. Chen HS and Sheen-Chen SM: Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery 127: 370-376, 2000. (Pubitemid 30225987)
10. Moertel CG, Fleming TR, MacDonald JS et al: Levamisole and fluoruracil for adjuvant therapy for resected colon carcinoma. N Eng J Med 6: 352-358, 1990. (Pubitemid 20042739)
11. Moertel CG, Fleming TR, MacDonald JS et al: Intergroup study of fluoruracil plus levamisole as adjuvant therapy for stage II/Dukes B2 colon cancer. J Clin Oncol 12: 2936-2943, 1995.
12. Lahnert T, Buhl K, Dueck M et al: Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol 26: 780-784, 2000. (Pubitemid 32059837)
13. Alcobendas F, Jorba R, Poves I et al: Perforated colonic cancer: evolution and prognosis. Rev Esp Enferm Dig 92(5): 326-333, 2000.
14. Gracia-Peche P: Factors of prognostic value in long term survival of colorectal cancer patients. Hepatogastroenterolo 38: 438-443, 1991.
15. Biondo S, Jaurrieta E, Rague JM et al: Role of resection and primary anastomosis of the left colon in the presence of peritonitis. Br J Surg 87: 80-84, 2000.
16. Gooszen AW, Tollenar RAEM, Geelkerken RH et al: Prospective study of primary anastomosis following sigmoid resection for suspected acute complicated diverticular disease. Br J Surg 88: 693-697, 2001. (Pubitemid 34014639)
17. Hoemke M, Treckman J, Schmitz R et al: Complicated diverticulitis of the sigmoid: a prospective study concerning primary resection with secure primary anastomosis. Dig Surg 16: 420-424, 1999. (Pubitemid 29520961)
18. Krivanek S, Armbruster C, Dittrich K et al: Perforated colorectal cancer. Dis Colon Rectum 39: 1409-1414, 1996.
19. Bielecki K, Kaminski P and Klukowski M: Large bowel perforation: morbidity and mortality. Tech Coloproctol 6: 177-182, 2002. (Pubitemid 36134389)
20. Minopoulos GI, Lyratzopoulas N, Efremidou HI et al: Emergency operations for carcinoma of the colon. Tech Coloproctol 8: S235-S237, 2004.
21. Saltz IB, Cox JV, Blanke C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group. N Eng J Med 343: 905-914, 2000. (Pubitemid 30727802)
22. Goldberg RM, Sargent DJ, Morton RF et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30, 2004. (Pubitemid 41095110)
23. Tournigand C, Andre T, Achille E et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in sdvanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237, 2004. (Pubitemid 41095086)
24. Koppe MJ, Boerman OC, Oyen WJG et al: Peritoneal carcimatosis of colorectal origin incidence and current treatment strategies. Ann Surg 243(2): 212-222, 2006. (Pubitemid 43185440)